Your browser doesn't support javascript.
loading
Dealing with doping. A plea for better science, governance and education.
Heuberger, Jules A A C; Henning, April; Cohen, Adam F; Kayser, Bengt.
Affiliation
  • Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands.
  • Henning A; Faculty of Health Sciences and Sport, University of Stirling, UK.
  • Cohen AF; DDCD Consulting, Oegstgeest, The Netherlands.
  • Kayser B; Institute of Sports Science, University of Lausanne, Switzerland.
Br J Clin Pharmacol ; 88(2): 566-578, 2022 02.
Article in En | MEDLINE | ID: mdl-34291479
ABSTRACT
The creation of WADA contributed to harmonization of anti-doping and changed doping behavior and prevalence in the past 22 years. However, the system has developed important deficiencies and limitations that are causing harm to sports, athletes and society. These issues are related to the lack of evidence for most substances on the Prohibited List for performance or negative health effects, a lack of transparency and accountability of governance and decision-making by WADA and the extension of anti-doping policies outside the field of professional sports. This article tries to identify these deficiencies and limitations and presents a plea for more science, better governance and more education. This should lead to a discussion for reform among stakeholders, which should cover support of a new Prohibited List by actual research and evidence and introduce better governance with accountable control bodies and regulation. Finally, comprehensive education for all stakeholders will be the basis of all future positive improvements.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sports / Doping in Sports Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sports / Doping in Sports Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: Netherlands